@article {4307,
	title = {Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community.},
	journal = {Contemporary clinical trials},
	year = {2014},
	month = {2014 Sep 18},
	abstract = {People with opioid dependence and HIV are concentrated within criminal justice settings (CJS). Upon release, however, drug relapse is common and contributes to poor HIV treatment outcomes, increased HIV transmission risk, reincarceration and mortality. Extended-release naltrexone (XR-NTX) is an evidence-based treatment for opioid dependence, yet is not routinely available for CJS populations.},
	issn = {1559-2030},
	doi = {10.1016/j.cct.2014.09.002},
	author = {Di Paola, Angela and Lincoln, Thomas and Skiest, Daniel J and Desabrais, Maureen and Altice, Frederick L and Springer, Sandra A}
}
